Related Experiment Video
Updated: Aug 1, 2026

The WinCF Model - An Inexpensive and Tractable Microcosm of a Mucus Plugged Bronchiole to Study the Microbiology of Lung Infections
Published on: May 8, 2017
Association between Stenotrophomonas maltophilia and lung function in cystic fibrosis
C H Goss1, N Mayer-Hamblett, M L Aitken
1Department of Medicine, University of Washington Medical Center, Seattle, WA 98195, USA. goss@u.washington.edu
Background:
Stenotrophomonas maltophilia (SM) is a Gram-negative non-fermenting bacteria cultured from the sputum of patients with cystic fibrosis (CF). To date, no information is available regarding the effect of this organism on lung function in CF.
Methods:
A cohort study was conducted to assess the effect of SM on lung function among CF patients aged > or =6 years in the CF Foundation National Patient Registry from 1994 to 1999. Repeated measures regression was used to assess the association between SM and lung function.
Results:
The cohort consisted of 20 755 patients with median age at entry of 13.8 years and median follow up time of 3.8 years; 2739 patients (13%) were positive at least once for SM and 18 016 (87%) were never positive. After adjusting for sex, height and age, patients with SM had a mean forced expiratory volume in 1 second which was 0.09 l less (95% CI 0.05 to 0.14) than those without SM. The mean rate of decline associated with SM positivity was 0.025 l/year (95% CI 0.012 to 0.037) but, after adjusting for confounders (sex, height, weight, intravenous antibiotic courses, hospital admissions, pancreatic insufficiency, and Pseudomonas aeruginosa and Burkholderia cepacia status), the mean rate of decline decreased to 0.008 l/year (-0.008, 95% CI -0.019 to 0.003).
Conclusions:
Although CF patients with SM have worse lung function at the time of positivity, no association was found between SM and increased rate of decline after controlling for confounders.
Insights
Stenotrophomonas maltophilia (SM) infection in cystic fibrosis (CF) patients is linked to worse initial lung function. However, SM does not appear to accelerate lung function decline in CF patients after accounting for other factors.
Area of Science:
- Medical Microbiology
- Pulmonology
- Epidemiology
Background:
- Stenotrophomonas maltophilia (SM) is a Gram-negative bacterium found in cystic fibrosis (CF) patients.
- The impact of SM on lung function in CF has not been previously documented.
Purpose of the Study:
- To investigate the association between SM infection and lung function in individuals with CF.
- To determine if SM influences the rate of lung function decline in CF patients.
Main Methods:
- A cohort study analyzed data from the CF Foundation National Patient Registry (1994-1999).
- Included CF patients aged 6 years and older.
- Repeated measures regression assessed the relationship between SM and lung function (Forced Expiratory Volume in 1 second - FEV1).
Main Results:
- The study cohort comprised 20,755 CF patients; 13% tested positive for SM at least once.
- SM-positive patients exhibited lower FEV1 at the time of positivity (mean difference: 0.09 L).
- After adjusting for confounders, the association between SM and an increased rate of FEV1 decline was not statistically significant (mean decline: 0.008 L/year).
Conclusions:
- CF patients infected with SM demonstrate poorer lung function at the point of detection.
- No significant association was found between SM infection and an accelerated rate of lung function decline in CF patients when controlling for key confounding variables.
Related Concept Videos
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
Sputum Studies I: Gram Stain, cytology, and Acid-fast smear and culture
Gram Stain
The Gram Stain is an integral part of sputum studies. It involves the staining of sputum, which permits...
Microbiota of the Respiratory Tract
Pneumonia I: Introduction

